Issued Patents All Time
Showing 1–25 of 32 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12421557 | Methods for predicting outcomes and treating colorectal cancer using a cell atlas | Aviv Regev, Nir Hacohen, Ana Carrizosa Anderson, Orit Rozenblatt-Rosen, Jonathan Chen +2 more | 2025-09-23 |
| 12241053 | Modulation of novel immune checkpoint targets | Ana Carrizosa Anderson, Asaf Madi, Norio CHIHARA, Aviv Regev, Meromit Singer | 2025-03-04 |
| 12195725 | Compositions and methods for modulating and detecting tissue specific TH17 cell pathogenicity | Meromit Singer, Alexandra Schnell, Aviv Regev | 2025-01-14 |
| 12161694 | Methods and compositions for regulating innate lymphoid cell inflammatory responses | Antonia Wallrapp, Samantha J. Riesenfeld, Patrick R. Burkett, Monika Kowalczyk, Aviv Regev | 2024-12-10 |
| 12049643 | Methods and compositions for modulating cytotoxic lymphocyte activity | Aviv Regev, Ana Carrizosa Anderson, Sema Kurtulus, Asaf Madi | 2024-07-30 |
| 11981922 | Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment | Meromit Singer, Aviv Regev, Orit Rozenblatt-Rosen, Davide Mangani, Ana Carrizosa Anderson +1 more | 2024-05-14 |
| 11957695 | Methods and compositions targeting glucocorticoid signaling for modulating immune responses | Ana Carrizosa Anderson, Asaf Madi, Nandini Acharya, Aviv Regev | 2024-04-16 |
| 11884717 | Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) protein | Chao Wang, Aviv Regev, Karthik Shekhar | 2024-01-30 |
| 11793787 | Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis | Ana Carrizosa Anderson, Asaf Madi, Nandini Acharya, Aviv Regev | 2023-10-24 |
| 11427869 | T cell balance gene expression, compositions of matters and methods of use thereof | Aviv Regev, Jellert Gaublomme, Youjin Lee, Chao Wang, Nir Yosef +2 more | 2022-08-30 |
| 11209440 | T cell balance gene expression, compositions of matters and methods of use thereof | Aviv Regev, Jellert Gaublomme, Youjin Lee, Alexander K. Shalek, Chao Wang +2 more | 2021-12-28 |
| 11186825 | Compositions and methods for evaluating and modulating immune responses by detecting and targeting POU2AF1 | Aviv Regev, Ana Carrizosa Anderson, Le Cong, Meromit Singer, Chao Wang | 2021-11-30 |
| 11180730 | Compositions and methods for evaluating and modulating immune responses by detecting and targeting GATA3 | Aviv Regev, Ana Carrizosa Anderson, Le Cong, Meromit Singer, Chao Wang | 2021-11-23 |
| 11001622 | Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) protein | Chao Wang, Aviv Regev, Karthik Shekhar | 2021-05-11 |
| 10934352 | Bi-specific antibodies against Tim-3 and PD-1 for immunotherapy in chronic immune conditions | Ana Carrizosa Anderson | 2021-03-02 |
| 10822587 | T cell balance gene expression, compositions of matters and methods of use thereof | Aviv Regev, Hongkun Park, Nir Yosef, Alexander K. Shalek, Jellert Gaublomme +3 more | 2020-11-03 |
| 10513540 | Modulation of the immune response | Richard S. Blumberg, Yu-Hwa Huang, Chen Zhu, Ana Carrizosa Anderson | 2019-12-24 |
| 9962440 | Methods related to TIM 3, a TH1-specific cell surface molecule, for activating antigen presenting cells | Sumone Chakravarti, Catherine Anne Sabatos-Peyton, Gordon J. Freeman | 2018-05-08 |
| 9834607 | Bi-specific antibodies against Tim-3 and PD-1 for immunotherapy in chronic immune conditions | Ana Carrizosa Anderson | 2017-12-05 |
| 9732320 | Selective differentiation, identification, and modulation of human TH17 cells | David E. Anderson, Estelle Bettelli, David A. Hafler, Mohammed Oukka | 2017-08-15 |
| 9580684 | Methods and compositions for the generation and maintenance of regulatory T cells | Arlene H. Sharpe, Loise M. Francisco | 2017-02-28 |
| 9346876 | TIM-3 ligands and methods of modulating immune responses | Terry B. Strom, Eugene K. Cha, Sumone Chakravarti, Catherine Anne Sabatos-Peyton, Chen Zhu +2 more | 2016-05-24 |
| 9333256 | Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells | Laurent Monney, Jason L. Gaglia, Edward A. Greenfield, Gordon J. Freeman, Hanspeter Waldner | 2016-05-10 |
| 9163087 | Bi-specific antibodies against TIM-3 and PD-1 for immunotherapy in chronic immune conditions | Ana Carrizosa Anderson | 2015-10-20 |
| 8697069 | Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells | Laurent Monney, Jason L. Gaglia, Edward A. Greenfield, Gordon J. Freeman, Hanspeter Waldner | 2014-04-15 |